Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Gossamer Bio (GOSS) Leases (2022 - 2025)

Gossamer Bio's Leases history spans 4 years, with the latest figure at $4.1 million for Q4 2025.

  • For Q4 2025, Leases fell 19.14% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, down 19.14%, while the annual FY2025 figure was $4.1 million, 19.14% down from the prior year.
  • Leases reached $4.1 million in Q4 2025 per GOSS's latest filing, down from $4.4 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $7.9 million in Q1 2022 to a low of $1.7 million in Q2 2024.
  • Average Leases over 4 years is $4.8 million, with a median of $4.7 million recorded in 2025.
  • Peak YoY movement for Leases: tumbled 63.44% in 2024, then surged 174.85% in 2025.
  • A 4-year view of Leases shows it stood at $5.9 million in 2022, then tumbled by 47.01% to $3.1 million in 2023, then soared by 63.24% to $5.1 million in 2024, then decreased by 19.14% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Leases are $4.1 million (Q4 2025), $4.4 million (Q3 2025), and $4.6 million (Q2 2025).